Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study

Objectives To determine whether the use of incretin based drugs, compared with sulfonylureas, is associated with an increased risk of acute pancreatitis.Design Population based cohort study.Setting 680 general practices in the United Kingdom contributing to the Clinical Practice Research Datalink.Pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) 2014-04, Vol.348 (7957), p.g2780-g2780
Hauptverfasser:	Faillie, Jean-Luc, Azoulay, Laurent, Patenaude, Valerie, Hillaire-Buys, Dominique, Suissa, Samy
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Acute Disease Classification Clinical trials Cohort analysis Confidence intervals Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - drug therapy Dipeptidyl-Peptidase IV Inhibitors - adverse effects Drug abuse Drugs Family medical history Female Follow-Up Studies Gastrointestinal surgery Glucagon-Like Peptide 1 - analogs & derivatives Health risk assessment Humans Hypoglycemic Agents - adverse effects Incretins - adverse effects Insulin Kaplan-Meier Estimate Male Medical research Middle Aged Pancreas Pancreatitis Pancreatitis - chemically induced Population Population studies Prescription drugs Risk Studies Sulfonylurea Sulfonylurea Compounds - adverse effects Type 2 diabetes mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!